- $113.33m
- $135.22m
- $120.34m
Annual income statement for Arq, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 100 | 103 | 99.2 | 109 | 120 |
| Cost of Revenue | |||||
| Gross Profit | 34.7 | 22.5 | 31.9 | 39.4 | 33.5 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 92.1 | 115 | 113 | 112 | 173 |
| Operating Profit | 8.2 | -12.1 | -13.3 | -3.38 | -52.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 76.1 | -8.71 | -12.1 | -5.27 | -52.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 60.4 | -9 | -12.2 | -5.11 | -52.6 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 60.4 | -8.92 | -12.2 | -5.11 | -52.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 60.4 | -8.92 | -12.2 | -5.11 | -52.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 3.01 | -0.467 | -0.481 | -0.115 | -0.576 |